Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 28, Issue 1, 2007, Pages 31-36

  Karlidag, Turgut ^a   Cobanoglu, Bengu ^a   Keles, Erol ^a   Alpay, Hayrettin Cengiz ^a   Ozercan, Ibrahim ^a   Kaygusuz, Irfan ^a   Yalcin, Sinasi ^a   Sakallioglu, Oner ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN BAX; PROTEIN P53;

ADULT; AGED; ARTICLE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALE; NECK METASTASIS; OTORHINOLARYNGOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THYROID CARCINOMA; THYROID GLAND;

ADOLESCENT; ADULT; AGED; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33845348150     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2006.06.008     Document Type: Article

References (25)

1. Kebebew E., and Clark O.H. Differentiated thyroid cancer: "complete" rational approach. World J Surg 24 (2000) 942-951
2. Hundahl S.A., Fleming I.D., Fremgen A.M., et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83 (1998) 2638-2648
3. Hay I.D., Bergstralh E.J., Goellner J.R., et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at an institution during 1940 through 1989. Surgery 114 (1993) 1050-1058
4. Shaha A.R. Management of the neck in thyroid cancer. Otolaryngol Clin North Am 31 (1998) 823-831
5. Grebe S.K., and Hay I.D. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5 (1996) 43-63
6. Khoo M.L.C., Freeman J.L., Witterick I.J., et al. Underexpression of p27/Kip in Thyroid papillary microcarcinomas with gross metastatic disease. Arch Otolaryngol Head Neck Surg 128 (2002) 253-257
7. Resnick M.B., Schacter P., Finkelstein Y., et al. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Mod Pathol 11 (1998) 735-739
8. Lloyd R.V., Jin L., Qian X., et al. Aberrant p27/kip1 expression in endocrine and other tumors. Am J Pathol 150 (1997) 401-407
9. Florenes V.A., Maelandsmo G.M., Kerbel R., et al. Protein expression of the cell-cycle inhibitor p27/Kip1 in malignant melanoma. Am J Pathol 153 (1998) 305-312
10. Steeg P.S., and Abrams J.S. Cancer prognostics: past, present and p27/Kip1. Nat Med 3 (1997) 152-154
11. Donghi R., Longoni A., Pilotti S., et al. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 91 (1993) 1753-1760
12. Manetto V., Lorenzini R., Cordon-Cardo C., et al. Bcl-2 and Bax expression in thyroid tumours. An immunohistochemical and western blot analysis. Virchows Arch 430 (1997) 125-130
13. Hermann S., Sturm I., Mrozek A., et al. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma. Int J Cancer 92 (2001) 805-811
14. Bhattacharyya N. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Otolaryngol Head Neck Surg 128 (2003) 115-123
15. Hughes C.J., Shaha A.R., Shah J.P., et al. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 18 (1996) 127-132
16. Beasley N.J.P., Lee J., Eski S., et al. Impact of nodal metastases on prognosis in patients with well differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 128 (2002) 825-828
17. Wang T.S., Dubner S., Sznyter L.A., et al. Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes. Arch Otolaryngol Head Neck Surg 130 (2004) 110-113
18. Mazzaferri E.L., and Jhiang S.M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97 (1994) 418-428
19. Farid P., Gomb S.Z., Peter I., et al. Bcl2, p53 and bax in thyroid tumors and their relation to apoptosis. Neoplasma 48 (2001) 299-301
20. Hosal S.A., Apel R.L., Freeman J.L., et al. Immunohistochemical localization of p53 in human thyroid neoplasms-correlation with biological behavior. Endocr Pathol 8 (1997) 21-28
21. Godballe C., Asschenfeldt P., Jorgensen K.E., et al. Prognostic factors in papillary and follicular thyroid carcinomas: p53 expression is a significant indicator of prognosis. Laryngoscope 108 (1998) 243-249
22. Dobashi Y., Sakamoto A., Sugiyama H., et al. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Path 17 (1993) 375-381
23. Erickson L.A., Yousef O.M., Jin L., et al. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma. Mod Pathol 13 (2000) 1014-1019
24. Tallini G., Garcia-Rostan G., Herrero A., et al. Downregulation of p27KIP1 and KI67/MIB-1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol 23 (1999) 678-685
25. Gross N.D., Weissman J.L., Talbot J.M., et al. MRI detection of cervical metastasis from differentiated thyroid carcinoma. Laryngoscope 111 (2001) 1905-1909